Letter to the Editor re: Is It Time to Rethink Our Approach to Overactive Bladder Treatment?

Roger R. Dmochowski
DOI: https://doi.org/10.1097/spv.0000000000001518
2024-05-01
Female Pelvic Medicine & Reconstructive Surgery
Abstract:The recent commentary, "Is It Time to Rethink Our Approach to Overactive Bladder Treatment?" by Alagh and Ramm published in the November 2023 issue of this journal, 1 details the impact of overactive bladder (OAB) on patients and examines emerging concerns with anticholinergic treatments for OAB. Discussion of anticholinergic safety is timely given recent evidence describing anticholinergic-associated risks, including a systematic review and meta-analysis that found an estimated 46% increased risk of dementia with ≥3 months of anticholinergic use compared with nonuse. 2
obstetrics & gynecology
What problem does this paper attempt to address?